Photo:
shformacion.es
Apr 19, 2026, 13:52
David Montani: SOX17 Variants and Their Broader Impact in Pulmonary Arterial Hypertension
David Montani, Professor of Pulmonology and Hospital Practitioner at Paris-Saclay University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in International Journal of Cardiology:
“Happy to share this editorial, written with Thomas Lacoste-Palasset, Julien Grynblat, Grégoire Ruffenach, and Florence Coulet: ‘SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype’.”
Title: SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype
Authors: Thomas Lacoste-Palasset, Julien Grynblat, Gregoire Ruffenach, Florence Coulet, David Montani
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026